<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Clinical Neurosciences</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/66E0C3E6-0A74-4971-97A0-79316875C8C2"><gtr:id>66E0C3E6-0A74-4971-97A0-79316875C8C2</gtr:id><gtr:firstName>Elizabeth</gtr:firstName><gtr:surname>Warburton</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6C483069-8D3A-498D-8435-56F37F66DEBB"><gtr:id>6C483069-8D3A-498D-8435-56F37F66DEBB</gtr:id><gtr:firstName>Jean-Claude</gtr:firstName><gtr:surname>Baron</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/5638B83E-8513-4CEC-A4BD-0C0805F4A22C"><gtr:id>5638B83E-8513-4CEC-A4BD-0C0805F4A22C</gtr:id><gtr:firstName>Franklin</gtr:firstName><gtr:otherNames>Imo</gtr:otherNames><gtr:surname>Aigbirhio</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0500874"><gtr:id>F83B87FC-B58E-41CD-8628-FEDA12A7C996</gtr:id><gtr:title>Imaging the surviving penumbra and recovery after stroke</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0500874</gtr:grantReference><gtr:abstractText>In the UK, stroke is the third cause of death and first cause of acquired disability, despite some degree of recovery in most survivors. Acutely reopening the blood vessel with thrombolysis salvages some tissue from infarction and improves outcome but does not always result in sufficient recovery. This may be due to death of brain cells in and inflammation of the salvaged tissue, in spite, or even perhaps because, of restoring blood flow. These lesions might prevent normal function of the remaining healthy cells to resume. Better understanding these processes might lead to novel approaches for treatment, in order to improve outcome after stroke. In this programme of research, we will use novel imaging techniques to tackle these issues in acute stroke patients.</gtr:abstractText><gtr:technicalSummary>Stroke is the third leading cause of death and the first of severe disability in the UK. Outcome after ischaemic stroke is a complex function of damage (the infarct) and plasticity, so limiting the former and promoting the latter are key goals. In middle cerebral artery (MCA) stroke - the most frequent subtype - the main determinant of clinical outcome is whether, and how extensively, the penumbra (i.e. the functionally impaired but viable ischaemic tissue) progresses to or escapes infarction. This underpins the rationale for early recanalization using thrombolysis in MCA stroke. However, not all patients with stable recanalization enjoy satisfactory functional outcome. In this four-year programme, we propose to study two cellular processes known from animal work to develop in the surviving penumbra and that may impede recovery, namely selective neuronal loss (SNL) and microglia activation. We will also assess whether they are related, and whether they dampen network activation. Understanding them may lead to novel therapeutic approaches aiming to both maximise benefits from thrombolysis and improve outcome in ineligible patients.

We will study MCA stroke patients longitudinally, combining cutting-edge imaging techniques with relevant clinical and behavioural scales. Eligible patients will be those with presence of penumbra on acute-stage diffusion/perfusion MR, and subsequent recanalization on transcranial Dopplers. Two to three weeks later, they will undergo PET using validated and selective ligands to provide quantitative measures of neuronal integrity and microglial inflammation. We will test two main hypotheses, firstly that the severity of initial ischaemia determines the degree of subsequent SNL in the surviving penumbra, and secondly that clinical recovery is worse with greater degrees of SNL. We will also address whether microglial activation affects the surviving penumbra, whether this is proportional to the degree of initial hypoperfusion and/or selective neuronal loss, and whether it is beneficial or harmful to recovery.

In the second part of the study, a second sample of otherwise similar patients fulfilling the same inclusion criteria will undergo serial fMRI from two weeks onward, using tasks that they can do, and a subset will also undergo a PET study of neuronal integrity. We will assess whether SNL interferes with functional activation, and whether the latter gradually resumes in the surviving penumbra to support clinical recovery.

These ?proof-of-principle? studies are meant to forerun larger-scale trials, potentially leading to randomized trials of interventions aiming to curb any detrimental processes occurring in the salvaged penumbra.</gtr:technicalSummary><gtr:fund><gtr:end>2010-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-03-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>843339</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>50EA0C36-35DF-4A3A-97BA-CDB2AE56D533</gtr:id><gtr:title>Selective neuronal loss in rescued penumbra relates to initial hypoperfusion.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b65d862c853d33d49a3c79cdf410720"><gtr:id>7b65d862c853d33d49a3c79cdf410720</gtr:id><gtr:otherNames>Guadagno JV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>62FB92452AA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>53A7D72D-7223-44BC-9512-7489AB938044</gtr:id><gtr:title>The neural substrates of impaired finger tapping regularity after stroke.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ddea57d74cb980c49f69c201d00ea108"><gtr:id>ddea57d74cb980c49f69c201d00ea108</gtr:id><gtr:otherNames>Calautti C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>pm_15876_26_20004249</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E8D9F1B3-CE21-492A-82CF-84409AC37D19</gtr:id><gtr:title>The vascular mean transit time: a surrogate for the penumbra flow threshold?</gtr:title><gtr:parentPublicationTitle>Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d2cea4aee87f8a43aeff848e8f1e47ba"><gtr:id>d2cea4aee87f8a43aeff848e8f1e47ba</gtr:id><gtr:otherNames>Carrera E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0271-678X</gtr:issn><gtr:outcomeId>pm_15876_26_21045862</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6EB582F-4B40-4331-ACF3-E06A745C8438</gtr:id><gtr:title>Infarction of 'non-core-non-penumbral' tissue after stroke: multivariate modelling of clinical impact.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a9539a882bfa457820d2abf598c805f0"><gtr:id>a9539a882bfa457820d2abf598c805f0</gtr:id><gtr:otherNames>Alawneh JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_15876_26_21616971</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EBE83E39-936E-4A6F-932A-C2DFB03420F6</gtr:id><gtr:title>Is neural activation within the rescued penumbra impeded by selective neuronal loss?</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d2cea4aee87f8a43aeff848e8f1e47ba"><gtr:id>d2cea4aee87f8a43aeff848e8f1e47ba</gtr:id><gtr:otherNames>Carrera E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_15876_26_23682070</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0E91A9E-88F3-43C9-9681-7A1D9990610F</gtr:id><gtr:title>Dominant hemisphere functional networks compensate for structural connectivity loss to preserve phonological retrieval with aging.</gtr:title><gtr:parentPublicationTitle>Brain and behavior</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e71debaa19483b3f0fbdea445002077"><gtr:id>4e71debaa19483b3f0fbdea445002077</gtr:id><gtr:otherNames>Agarwal S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>585d317edb1a70.55497024</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4653AF8D-AB72-44AB-B938-488530FDE07C</gtr:id><gtr:title>Predicting infarction within the diffusion-weighted imaging lesion: does the mean transit time have added value?</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d2cea4aee87f8a43aeff848e8f1e47ba"><gtr:id>d2cea4aee87f8a43aeff848e8f1e47ba</gtr:id><gtr:otherNames>Carrera E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>pm_15876_26_21512183</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>81572BFA-77E5-4ACC-BA07-71FFF7BCCA2E</gtr:id><gtr:title>Diffusion and perfusion correlates of the 18F-MISO PET lesion in acute stroke: pilot study.</gtr:title><gtr:parentPublicationTitle>European journal of nuclear medicine and molecular imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a9539a882bfa457820d2abf598c805f0"><gtr:id>a9539a882bfa457820d2abf598c805f0</gtr:id><gtr:otherNames>Alawneh JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1619-7070</gtr:issn><gtr:outcomeId>pm_540e141e141af315b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B61EAD6-18FC-41B3-945C-7F0009959684</gtr:id><gtr:title>A comparison of VLSM and VBM in a cohort of patients with post-stroke aphasia.</gtr:title><gtr:parentPublicationTitle>NeuroImage. Clinical</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d02fb6a36b2876e129d8a8f3f9f8f63b"><gtr:id>d02fb6a36b2876e129d8a8f3f9f8f63b</gtr:id><gtr:otherNames>Geva S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2213-1582</gtr:issn><gtr:outcomeId>pm_15876_26_24179735</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC3C6676-0CC1-46E2-9460-C56DC5A73471</gtr:id><gtr:title>The neural correlates of inner speech defined by voxel-based lesion-symptom mapping.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d02fb6a36b2876e129d8a8f3f9f8f63b"><gtr:id>d02fb6a36b2876e129d8a8f3f9f8f63b</gtr:id><gtr:otherNames>Geva S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_15876_26_21975590</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F7E5770-C2F5-48E3-890B-F437F03A5011</gtr:id><gtr:title>Interaction of age with the ischaemic penumbra, leptomeningeal collateral circulation and haemodynamic variables in acute stroke: a pilot study.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e71debaa19483b3f0fbdea445002077"><gtr:id>4e71debaa19483b3f0fbdea445002077</gtr:id><gtr:otherNames>Agarwal S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_15876_26_23178505</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CB2FAD96-661D-4298-997E-8A78D7A9BAF9</gtr:id><gtr:title>Selective neuronal loss in ischemic stroke and cerebrovascular disease.</gtr:title><gtr:parentPublicationTitle>Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d7fb06edfb9f77f45f51b6c2af414e7"><gtr:id>6d7fb06edfb9f77f45f51b6c2af414e7</gtr:id><gtr:otherNames>Baron JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0271-678X</gtr:issn><gtr:outcomeId>pm_15876_26_24192635</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>524A2B11-F200-4838-975E-F91978488254</gtr:id><gtr:title>The effect of aging on the neural correlates of phonological word retrieval.</gtr:title><gtr:parentPublicationTitle>Journal of cognitive neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d02fb6a36b2876e129d8a8f3f9f8f63b"><gtr:id>d02fb6a36b2876e129d8a8f3f9f8f63b</gtr:id><gtr:otherNames>Geva S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0898-929X</gtr:issn><gtr:outcomeId>pm_15876_26_22849403</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C10E734A-5350-4510-85AD-17CD2D0ED8E0</gtr:id><gtr:title>Contributions of bilateral white matter to chronic aphasia symptoms as assessed by diffusion tensor MRI.</gtr:title><gtr:parentPublicationTitle>Brain and language</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d02fb6a36b2876e129d8a8f3f9f8f63b"><gtr:id>d02fb6a36b2876e129d8a8f3f9f8f63b</gtr:id><gtr:otherNames>Geva S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0093-934X</gtr:issn><gtr:outcomeId>585d57370d3f78.99897824</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>566CE62E-2801-4D27-ADC0-5F67252DB36B</gtr:id><gtr:title>Penumbral selection of patients for trials of acute stroke therapy.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2afb3c4cfb3aa99ff05f7c82d547cca6"><gtr:id>2afb3c4cfb3aa99ff05f7c82d547cca6</gtr:id><gtr:otherNames>Donnan GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>pm_15876_16_19233036</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0500874</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>A77DAE3A-499B-4F46-971D-6C82F51F9C2E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Stroke</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>3BEA012A-C817-4067-8BE1-05331EBB5152</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>4.2  Evaluation of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>